Nomura Holdings Inc. Buys 2,985 Shares of Cardinal Health, Inc. $CAH

Key Points

• Nomura Holdings Inc. increased its stake in Cardinal Health by 30.5%, acquiring an additional 2,985 shares, bringing its total holdings to 12,768 shares worth approximately $1.76 million.
• Cardinal Health is set to pay a quarterly dividend of $0.5107 per share on October 15th, which equates to an annualized yield of 1.4%.
• The company reported earnings of $2.08 per share for the last quarter, surpassing analysts' estimates of $2.03, while its revenue was $60.16 billion.

Nomura Holdings Inc. boosted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 30.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,768 shares of the company's stock after acquiring an additional 2,985 shares during the quarter. Nomura Holdings Inc.'s holdings in Cardinal Health were worth $1,759,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. bought a new stake in Cardinal Health in the 1st quarter valued at $26,000. Tompkins Financial Corp lifted its position in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares in the last quarter. GW&K Investment Management LLC lifted its position in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares in the last quarter. Measured Risk Portfolios Inc. bought a new stake in Cardinal Health in the 4th quarter valued at $47,000. Finally, NBC Securities Inc. bought a new stake in Cardinal Health in the 1st quarter valued at $48,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 0.5%

Shares of CAH opened at $149.54 on Wednesday. The company has a market cap of $35.71 billion, a price-to-earnings ratio of 23.18, a PEG ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44. The company's fifty day simple moving average is $156.81 and its 200 day simple moving average is $146.48.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the company earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's payout ratio is presently 31.63%.

Insider Buying and Selling at Cardinal Health

In related news, CEO Jason M. Hollar sold 107,705 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the transaction, the chief executive officer directly owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. Company insiders own 0.09% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Evercore ISI lowered their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th. Citigroup reiterated a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Robert W. Baird lifted their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Leerink Partners lowered their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a report on Tuesday, August 12th. Finally, Bank of America lifted their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday, June 10th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and an average target price of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.